News Lilly’s RA drug Olumiant gains first approval in Europe Oral treatment could take the lead among next generation RA drugs
News Sanofi's Kevzara gains first approval in Canada Sanofi and Regeneron's new rheumatoid arthritis (RA) drug Kevzara has gained its first global approval in Canada.
News Delinia adds to Celgene's immunology ambitions Celgene continues with focus on autoimmune diseases.
News Amgen's Humira biosimilar first to gain EU nod But patents could delay launch for more than a year.
News Novo sues Lilly over 'misleading' GLP-1 ad campaigning The rivalry between Novo Nordisk and Eli Lilly in the GLP-1 market has spilled over into the courts in the US, with claims of misleading advertising.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
